regularly interspaced short palindromic repeats programmed find specific stretches genetic code cas9 enzyme attaches targeted dna cuts shutting gene approaches gene editing predate crispr including called zinc finger nucleases talens transcription activator like effector nucleases challenges crispr favorite research labs hoped people new study suggests longer crispr gene editing safe use patients problem not insurmountable bioengineer feng zhang helped develop technology wrote e mail open questions safety efficacy crispr based therapeutics wrote zhang core member broad institute massachusetts institute technology professor currently number different strategies pursued develop cas9 therapeutic design requires unique consideration safety efficacy zhang added designs enter advanced